Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-0943
Fax+1 608-263-9103
Dr. Andes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Infectious Disease, 1996 - 1999- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1992 - 1996
University of Missouri-Columbia School of MedicineClass of 1992
Certifications & Licensure
WI State Medical License 1993 - 2025
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Association of American Physicians Association of American Physicians, 2018
- American Academy of Microbiology - Fellow American Academy of Microbiology, 2017
- Regional Top Doctor Castle Connolly, 2014
- Join now to see all
Publications & Presentations
PubMed
- Plasma microbial cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High Risk Outpatient and Inpatient Immunocompromised Hosts.Beatrice Z Sim, Jordan K Mah, Madeleine R Heldman, Kelly L Stanly, Kimberly E Hanson
Clinical Infectious Diseases. 2025-04-03 - biofilm extracellular vesicles deliver candidalysin to epithelial cell membranes and induce host cell responses.Sejeong Lee, Antzela Tsavou, Robert Zarnowski, Rita Pforte, Stefanie Allert
Infection and Immunity. 2025-04-02 - Characterizing extracellular vesicles of human fungal pathogens.Marcio L Rodrigues, Guilhem Janbon, Richard J O'Connell, Thi-Thu-Huyen Chu, Robin C May
Nature Microbiology. 2025-04-01
Press Mentions
The Fight Against FungiFebruary 28th, 2021- UWCCC Small Molecule Screening Facility Validates the Lumit™ Dx SARS-CoV-2 Immunoassay for High-Throughput SARS-CoV-2 Antibody ScreeningJanuary 4th, 2021
- Hospitals Stretched Beyond 'Reasonable Limit' as Number of COVID-19 Patients Reaches 100,000December 3rd, 2020
- Join now to see all
Grant Support
- Vesicle-mediated drug resistance of Candida albicans biofilmUNIVERSITY OF WISCONSIN-MADISON2008–2029
- Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungiUNIVERSITY OF WISCONSIN-MADISON2022–2027
- Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training CourseMARINE BIOLOGICAL LABORATORY2021–2026
- Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training CourseMARINE BIOLOGICAL LABORATORY2021–2026
- Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training CourseMARINE BIOLOGICAL LABORATORY2021–2026
- Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training CourseMARINE BIOLOGICAL LABORATORY2021–2026
- Novel antimicrobials targeting MDR pathogens from animal microbial symbiontsUNIVERSITY OF WISCONSIN-MADISON2019–2025
- Development of non-toxic amphotericin B derivatives targeting invasive fungal infectionsUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN2018–2025
- Training In The Use Of Bruker And Varian Spectrometers And NMRNational Center For Research Resources2010
- Fluconazole-Biofilm Matrix In Candida AlbicansNational Center For Research Resources2010
- Pharmacodynamics In Antifungal ResistanceNational Institute Of Allergy And Infectious Diseases2001–2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
